1Fainstein Day P, Guitelman M, Artese R, et al. Retrospective multicentric study of pituitary incidentalomas[J]. Pituitary, 2004,7:145--148
2Martin SW, Lefton DR, Pinto RS, et al. MR imaging characteristics of amyloid deposits in pituitary adenoma[J]. AJNR Am J Neuroradiol, 2002,23 : 368-- 370.
3Vaneekova M, Seidl Z, Hana V,et al. Macroprolactinomas: retrospective follow up study in the MR imaging and correlation with clinical symptomatology[J]. Neuro Endoerinol Lett, 2007,28:841 -- 845.
4Gokalp HZ, Deda H, Attar A, et al. The neurosurgical management of prolactinomas[J]. J Neurosurg Sci,2000,44:128-- 132.
5Moussa R, Roux FX, Nataf F, et al. Controversies in the management of operated pituitary macroadenomas[J]. Neurochirurgie, 1998,44 : 352-- 359.
6Kreutzer J, Buslei R, Wallaschofski H, et al. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients[J]. Eur J Endocrinol, 2008, 158..11--18.
7Jain AK, Gupta AK, Pathak A, et al. Excision of pituitary adenomas., randomized comparison of surgical modalities[J]. Br J Neurosurg,2007,21:328--331.
8Frank G, Pasquini E, Farneti G, et al. The endoscopic versus the traditional approach in pituitary surgery[J]. Neuroendocrinology, 2006,83 : 240-- 248.
9Sandoval Sanchez JH, Flores--Cardenas F, Vargas--Frutos MC, et al. Complications of the direct endonasal transsphenoidal approach in the management of pituitary adenomas[J]. Neurocirugia ( Astur), 2007,18 : 485-- 491.
10Saito T, Watanabe Y, Yuzawa M, et al. SIADH is only an atypical clinical feature in a patient with prolaetinoma[J]. Intern Med,Z007,46 : 653-- 656.
